The EU reportedly intends to levy a "significant" fine on Lundbeck (HLUYY.PK) for limiting access to cheaper drugs through "pay for delay" deals in which brand name companies pay generic manufacturers not to enter the market with their products. The EU also plans to impose lighter penalties on Merck KGaA (MKGAF.PK) and seven smaller generic firms. The issue has aroused much controversy in the U.S., where a case has been heard by the Supreme Court.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs